Clinical Evaluation of Oral Chronic Graft-Versus-Host Disease

Slides:



Advertisements
Similar presentations
Steven Joffe, Michelle M. Mello, E. Francis Cook, Stephanie J. Lee 
Advertisements

Stephanie J. Lee, Loretta A. Williams 
Center for International Blood and Marrow Transplant Research Chronic Graft-versus- Host Disease Risk Score Predicts Mortality in an Independent Validation.
How to Treat MDS without Stem Cell Transplantation
Incidence and Prognostic Value of Eosinophilia in Chronic Graft-versus-Host Disease after Nonmyeloablative Hematopoietic Cell Transplantation  Imran Ahmad,
Steven Joffe, Michelle M. Mello, E. Francis Cook, Stephanie J. Lee 
Vaccination of Children following Allogeneic Stem Cell Transplantation
Pharmacokinetics of Ganciclovir after Oral Valganciclovir versus Intravenous Ganciclovir in Allogeneic Stem Cell Transplant Patients with Graft-versus-Host.
Extensive Dental Caries in Patients with Oral Chronic Graft-versus-Host Disease  Paolo Castellarin, Kristen Stevenson, Matteo Biasotto, Anna Yuan, Sook-Bin.
Sympathectomy Protects Denervated Skin from Graft-Versus-Host Disease
Daniela Ion, Kristen Stevenson, Sook-Bin Woo, Vincent T
A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft- versus-Host Disease  Alex F. Herrera, Haesook T. Kim, Bhavjot Bindra,
B Cells in Chronic Graft-versus-Host Disease
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker.
Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non- Hodgkin Lymphoma: Importance of Histology for Outcome  Philippe Armand,
Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation  Aazim K. Omer, Daniel J. Weisdorf, Aleksandr Lazaryan,
Oral Chronic Graft-versus-Host Disease in Pediatric Patients after Hematopoietic Stem Cell Transplantation  Nathaniel S. Treister, Sook-Bin Woo, Eileen.
Oral Manifestations Compatible with Chronic Graft-versus-Host Disease in Patients with Fanconi Anemia  Laura Grein Cavalcanti, Renata L. Fuentes Araújo,
Sabina Kersting, Leo F. Verdonck 
Genital Chronic Graft-versus-Host Disease in Females: A Cross-Sectional Study  Eva Smith Knutsson, Yvonne Björk, Anna-Karin Broman, Lotti Helström, Anne-Marie.
Musculoskeletal, Neurologic, and Cardiopulmonary Aspects of Physical Rehabilitation in Patients with Chronic Graft-versus-Host Disease  Sean Robinson.
Mammalian Target of Rapamycin Inhibitor–Associated Stomatitis in Hematopoietic Stem Cell Transplantation Patients Receiving Sirolimus Prophylaxis for.
Peripheral Blood Grafts from Unrelated Donors Are Associated with Increased Acute and Chronic Graft-versus-Host Disease without Improved Survival  Mary.
Outcome and Prognostic Factors for Patients Who Relapse after Allogeneic Hematopoietic Stem Cell Transplantation  Gita Thanarajasingam, Haesook T. Kim,
Stephanie J. Lee, Loretta A. Williams 
Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life
Clinical Benefit of Response in Chronic Graft-versus-Host Disease
Comparison of Short-Term Response and Long-Term Outcomes after Initial Systemic Treatment of Chronic Graft-Versus-Host Disease  Paul J. Martin, Barry.
Jennifer Crombie, Laura Spring, Shuli Li, Robert J. Soiffer, Joseph H
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary.
Should Methotrexate plus Calcineurin Inhibitors Be Considered Standard of Care for Prophylaxis of acute Graft-versus-Host Disease?  Rainer Storb, Joseph.
Late-Onset Colitis after Cord Blood Transplantation Is Consistent with Graft-Versus-Host Disease: Results of a Blinded Histopathological Review  Filippo.
Helicobacter pylori Infection and Graft-versus-Host Disease
Oral Chronic Graft-versus-Host Disease Scoring Using the NIH Consensus Criteria  Nathaniel S. Treister, Kristen Stevenson, MS, Haesook Kim, Sook-Bin Woo,
A Novel Strategy in Managing Post-Liver Transplant Acute Graft-Versus-Host-Disease: The New Era (T)Rojan Horse  Zeyad Kanaan, MD, William Tse, MD, FACP 
Betty K. Hamilton, Lisa Rybicki, Sally Arai, Mukta Arora, Corey S
Statistical Considerations in Studies of Late Effects in HCT
Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-
Post-Transplantation B Cell Activating Factor and B Cell Recovery before Onset of Chronic Graft-versus-Host Disease  Caron A. Jacobson, Lixian Sun, Haesook.
Iron Overload Manifesting as Apparent Exacerbation of Hepatic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation  Rammurti.
An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease 
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease.
Mucositis after Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study of Methotrexate- and Non-Methotrexate-Containing Graft-versus-Host.
Allogeneic Stem Cell Transplantation for Aplastic Anemia
Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data  Brent R. Logan, Mei-Jie Zhang,
Low-Dose IL-2 Therapy Preferentially Improves Diversity of the Regulatory T Cell Repertoire in Patients with Refractory Chronic Graft-Versus-Host Disease 
What is quality in a transplant program?
Issues of Aging and Geriatric Medicine: Relevance to Cancer Treatment and Hematopoietic Reconstitution  William B. Ershler, Andrew S. Artz, Evan T. Keller 
Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews  Emily C. Merkel, Sandra A. Mitchell,
Unrelated Stem Cell Transplantation after a Reduced Intensity Conditioning Regimen Containing High-Dose Thymoglobulin Leads to Controllable Graft-versus-Host.
John E. Levine, Sophie Paczesny, Stefanie Sarantopoulos 
Chimeric Antigen Receptor–Modified T Cells: Clinical Translation in Stem Cell Transplantation and Beyond  Stanley R. Riddell, Michael C. Jensen, Carl.
Manuel Jurado, Carlos Vallejo, José A
Karen K. Ballen, Thomas R. Spitzer, Beow Y
Blood and Marrow Transplant Handbook
Calcinuerin-Inhibitor (CI) Free Graft-Versus-Host Disease (GvHD) Prophylaxis: Its Effects on Magnesium, Renal Function, and the Cost of Care  Marlee Muilenburg,
A Prognostic Score for Patients with Acute Leukemia or Myelodysplastic Syndromes Undergoing Allogeneic Stem Cell Transplantation  Philippe Armand, Haesook.
Young Female Donors Do Not Increase the Risk of Graft-versus-Host Disease or Impact Overall Outcomes in Pediatric HLA-Matched Sibling Hematopoietic Stem.
Preengraftment Syndrome after Unrelated Cord Blood Transplant Is a Strong Predictor of Acute and Chronic Graft-versus-Host Disease  Haydar Frangoul, Li.
Low Serum Levels of Total Rabbit-IgG Is Associated with Acute Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation:
Alveolar Hemorrhage and Acute Graft-versus-Host Disease
Mammen Chandy  Biology of Blood and Marrow Transplantation 
Treatment versus Transplant for Challenging Hematologic Disorders
Adult Recipients of Matched Related Donor Blood Cell Transplants Given Myeloablative Regimens Including Pretransplant Antithymocyte Globulin Have Lower.
Mary Eapen  Biology of Blood and Marrow Transplantation 
In Memoriam: E. Donnall Thomas
Daniel Couriel, Chitra Hosing, Rima Saliba, Elizabeth J
Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease  Joseph Pidala, Jongphil Kim, Teresa Field, Ali McBride, Mohamed Kharfan-Dabaja,
Graft-versus-Host Disease: State of the Science
Graft-versus-Tumor Effect According to Type of Graft-versus-Host Disease Defined by National Institutes of Health Consensus Criteria and Associated Outcomes 
Presentation transcript:

Clinical Evaluation of Oral Chronic Graft-Versus-Host Disease Nathaniel S. Treister, Earl Francis Cook, Joseph Antin, Stephanie J. Lee, Robert Soiffer, Sook-Bin Woo  Biology of Blood and Marrow Transplantation  Volume 14, Issue 1, Pages 110-115 (January 2008) DOI: 10.1016/j.bbmt.2007.06.017 Copyright © 2008 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Oral mucosal cGVHD of the right buccal mucosa with reticular, erythematous, and ulcerative features. The unaffected mucosa is normal and pink. Biology of Blood and Marrow Transplantation 2008 14, 110-115DOI: (10.1016/j.bbmt.2007.06.017) Copyright © 2008 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Ulcerative and erythematous cGVHD of the palate. Biology of Blood and Marrow Transplantation 2008 14, 110-115DOI: (10.1016/j.bbmt.2007.06.017) Copyright © 2008 American Society for Blood and Marrow Transplantation Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.